Clinical Trial Update: Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating 611 in Chinese adolescents with moderate to severe atopic dermatitis is currently recruiting. The study is sponsored by Suns…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• 611

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Dermatitis, Atopic | Phase 3 | Status: RECRUITING